Review to better understand the macroscopic subtypes and histogenesis of intrahepatic cholangiocarcinoma.

Intrahepatic cholangiocarcinoma is macroscopically classified into three subtypes, mass-forming-type, periductal infiltrating-type, and intraductal growth-type. Each subtype should be preoperatively differentiated to perform the valid surgical resection. Recent researches have revealed the clinical, radiologic, pathobiological characteristics of each subtype. We reviewed recently published studies covering various aspects of intrahepatic cholangiocarcinoma (ICC), focusing especially on the macroscopic subtypes and stem cell features to better understand the pathophysiology of ICC and to establish the valid therapeutic strategy.

[1]  A. Stenzinger,et al.  The DNA index is a strong predictive marker in intrahepatic cholangiocarcinoma: the results of a five-year prospective study , 2014, Surgery Today.

[2]  H. Taniguchi,et al.  Cellular reprogramming and hepatocellular carcinoma development. , 2013, World journal of gastroenterology.

[3]  K. Boudjema,et al.  Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma , 2013, Hepatology.

[4]  S. Qiu,et al.  Elevation of serum &ggr;-glutamyltransferase as a predictor of aggressive tumor behaviors and unfavorable prognosis in patients with intrahepatic cholangiocarcinoma: analysis of a large monocenter study , 2013, European journal of gastroenterology & hepatology.

[5]  Y. Maehara,et al.  Decreased roundabout 1 expression promotes development of intrahepatic cholangiocarcinoma. , 2013, Human pathology.

[6]  Gi Jeong Kim,et al.  Increased Expression of Yes-Associated Protein 1 in Hepatocellular Carcinoma with Stemness and Combined Hepatocellular-Cholangiocarcinoma , 2013, PloS one.

[7]  M. Gu,et al.  Epithelial–mesenchymal transition phenotypes are associated with patient survival in intrahepatic cholangiocarcinoma , 2013, Journal of Clinical Pathology.

[8]  A. Ruzzenente,et al.  Patterns and Prognostic Significance of Lymph Node Dissection for Surgical Treatment of Perihilar and Intrahepatic Cholangiocarcinoma , 2013, Journal of Gastrointestinal Surgery.

[9]  Yasunori Sato,et al.  Clinicopathologic significance of combined hepatocellular-cholangiocarcinoma with stem cell subtype components with reference to the expression of putative stem cell markers. , 2013, American journal of clinical pathology.

[10]  Jian Zhang,et al.  Expression of cytoskeleton-associated protein 4 is related to lymphatic metastasis and indicates prognosis of intrahepatic cholangiocarcinoma patients after surgery resection. , 2013, Cancer letters.

[11]  Huifang Liang,et al.  Inactivation of Smad4 is a prognostic factor in intrahepatic cholangiocarcinoma , 2013, Chinese medical journal.

[12]  Y. Maehara,et al.  Different roles of inducible nitric oxide synthase and cyclooxygenase-2 in carcinogenesis and metastasis of intrahepatic cholangiocarcinoma. , 2013, Human pathology.

[13]  B. Peng,et al.  The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinoma , 2013, BMC Cancer.

[14]  H. Honda,et al.  Clinical usefulness of 18F‐fluorodeoxyglucose positron emission tomography/computed tomography for patients with primary liver cancer with special reference to rare histological types, hepatocellular carcinoma with sarcomatous change and combined hepatocellular and cholangiocarcinoma , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

[15]  T. Nagayasu,et al.  Clinical significances of cancer stem cells markers in patients with intrahepatic cholangiocarcinoma who underwent hepatectomy. , 2013, Anticancer research.

[16]  S. Hattori,et al.  Clinicopathologic Analysis of Combined Hepatocellular-Cholangiocarcinoma According to the Latest WHO Classification , 2013, The American journal of surgical pathology.

[17]  I. Ng,et al.  Hepatic progenitor cells: their role and functional significance in the new classification of primary liver cancers. , 2013, Liver cancer.

[18]  T. Limpaiboon,et al.  Ratio disruption of the ∆133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma. , 2013, International journal of oncology.

[19]  Kui Wang,et al.  Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Chi-Chih Wang,et al.  Clinicopathological factors impact the survival outcome following the resection of combined hepatocellular carcinoma and cholangiocarcinoma. , 2013, Surgical oncology.

[21]  K. Boudjema,et al.  Intrahepatic cholangiocarcinoma: impact of genetic hemochromatosis on outcome and overall survival after surgical resection. , 2013, The Journal of surgical research.

[22]  Yiqun Yan,et al.  Intrahepatic cholangiocarcinoma: a clinicopathologic study of 37 resected cases. , 2013, Hepato-gastroenterology.

[23]  Zhao-You Tang,et al.  High expression of Dickkopf‐related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery , 2013, Cancer.

[24]  R. Dhanasekaran,et al.  Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma , 2013, Oncology reports.

[25]  Jia Fan,et al.  Prognostic Significance of Capn4 Overexpression in Intrahepatic Cholangiocarcinoma , 2013, PloS one.

[26]  S. Hsieh,et al.  Comparison of clinical characteristics of combined hepatocellular‐cholangiocarcinoma and other primary liver cancers , 2013, Journal of gastroenterology and hepatology.

[27]  Y. Jeng,et al.  Expression of insulin-like growth factor II mRNA-binding protein 3 predicts early recurrence and poor prognosis in intrahepatic cholangiocarcinoma. , 2013, International journal of surgery.

[28]  M. Yano,et al.  Prediction of the Postoperative Prognosis of Intrahepatic Cholangiocarcinoma (ICC): Importance of Preoperatively-Determined Anatomic Invasion Level and Number of Tumors , 2013, Digestive Diseases and Sciences.

[29]  T. Nagayasu,et al.  Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics , 2013, Abdominal Imaging.

[30]  Guo-tao Lu,et al.  A High Level of Integrin α6 Expression in Human Intrahepatic Cholangiocarcinoma Cells Is Associated with a Migratory and Invasive Phenotype , 2013, Digestive Diseases and Sciences.

[31]  F. Giuliante,et al.  Prognostic Significance of Tumor Doubling Time in Mass-Forming Type Cholangiocarcinoma , 2013, Journal of Gastrointestinal Surgery.

[32]  Y. Jeng,et al.  S100P immunostaining identifies a subset of peripheral‐type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas , 2012, Histopathology.

[33]  S. Giulini,et al.  Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 434 Patients. , 2012, Archives of surgery.

[34]  Hyun Goo Woo,et al.  Transcriptomic profiling reveals hepatic stem‐like gene signatures and interplay of miR‐200c and epithelial‐mesenchymal transition in intrahepatic cholangiocarcinoma , 2012, Hepatology.

[35]  Chang Hee Lee,et al.  Typical and Atypical Imaging Findings of Intrahepatic Cholangiocarcinoma Using Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid–Enhanced Magnetic Resonance Imaging , 2012, Journal of computer assisted tomography.

[36]  R. Semelka,et al.  Combined hepatocellular carcinoma‐cholangiocarcinoma: Report of MR appearance in eleven patients , 2012, Journal of magnetic resonance imaging : JMRI.

[37]  W. Cong,et al.  Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular‐cholangiocarcinoma , 2012, Hepatology.

[38]  B. Li,et al.  Expression of HBx protein in hepatitis B virus-infected intrahepatic cholangiocarcinoma. , 2012, Hepatobiliary & pancreatic diseases international : HBPD INT.

[39]  X. Yao,et al.  Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma , 2012, OncoTargets and therapy.

[40]  Eun-Jung Jung,et al.  Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma. , 2012, Oncology reports.

[41]  Young Kon Kim,et al.  Differentiating combined hepatocellular and cholangiocarcinoma from mass‐forming intrahepatic cholangiocarcinoma using gadoxetic acid‐enhanced MRI , 2012, Journal of magnetic resonance imaging : JMRI.

[42]  K. Jang,et al.  Expression of keratin 20 and its clinicopathological significance in intrahepatic cholangiocarcinoma. , 2012, Oncology letters.

[43]  B. Choi,et al.  Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. , 2012, Radiology.

[44]  Bruno Clément,et al.  Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways. , 2012, Carcinogenesis.

[45]  J. Kinoshita,et al.  Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma. , 2012, International journal of oncology.

[46]  Hong-Wei Li,et al.  Clinical and pathological analysis of 27 patients with combined hepatocellular-cholangiocarcinoma in an Asian center , 2012, Journal of hepato-biliary-pancreatic sciences.

[47]  Yan Zhu,et al.  Down‐regulation of miR‐214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist , 2012, The FEBS journal.

[48]  Zhi-heng Liu,et al.  Factors influencing the prognosis of patients with intrahepatic cholangiocarcinoma. , 2012, Acta gastro-enterologica Belgica.

[49]  Bing Zeng,et al.  [Effect of hepatitis C virus core gene transfection on NFAT1 expression in human intrahepatic cholangiocarcinoma cells]. , 2012, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[50]  Ying Zhou,et al.  Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Clinical Features, Treatment Modalities, and Prognosis , 2012, Annals of Surgical Oncology.

[51]  Q. Gao,et al.  Intratumoral IL-17+ Cells and Neutrophils show Strong Prognostic Significance in Intrahepatic Cholangiocarcinoma , 2012, Annals of Surgical Oncology.

[52]  T. Utsunomiya,et al.  Role of histone deacetylase expression in intrahepatic cholangiocarcinoma. , 2012, Surgery.

[53]  H-X Xu,et al.  Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination. , 2012, The British journal of radiology.

[54]  H. Ojima,et al.  Periductal infiltrating type of intrahepatic cholangiocarcinoma: a rare macroscopic type without any apparent mass , 2012, Surgery Today.

[55]  Y. Jan,et al.  K-ras Mutation is Strongly Associated with Perineural Invasion and Represents an Independent Prognostic Factor of Intrahepatic Cholangiocarcinoma after Hepatectomy , 2012, Annals of Surgical Oncology.

[56]  S. Batra,et al.  Pathobiological Implications of MUC16/CA125 Expression in Intrahepatic Cholangiocarcinoma-Mass Forming Type , 2012, Pathobiology.

[57]  M. Gu,et al.  Clinicopathological significance of E-cadherin, β-catenin and epidermal growth factor receptor expression in intrahepatic cholangiocarcinoma. , 2012, Hepato-gastroenterology.

[58]  T. Wen,et al.  Predictive factors of recurrence for patients with intrahepatic cholangiocarcinoma after hepatectomy. , 2011, Hepato-gastroenterology.

[59]  T. Zheng,et al.  Immunohistochemical analysis of the mTOR pathway in intrahepatic cholangiocarcinoma. , 2012, Neoplasma.

[60]  Kyusam Choi,et al.  The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas , 2012, Modern Pathology.

[61]  Sopit Wongkham,et al.  High expression of ABCC1 indicates poor prognosis in intrahepatic cholangiocarcinoma. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[62]  Masakazu Yamamoto,et al.  Combined Hepatocellular–Cholangiocarcinoma Had Poor Outcomes after Hepatectomy Regardless of Allen and Lisa Class or the Predominance of Intrahepatic Cholangiocarcinoma Cells within the Tumor , 2012, Annals of Surgical Oncology.

[63]  Y. Murakami,et al.  Intrahepatic Cholangiocarcinoma: Clinicopathological Differences Between Peripheral Type and Hilar Type , 2012, Journal of Gastrointestinal Surgery.

[64]  T. Utsunomiya,et al.  Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma , 2012, Surgery Today.

[65]  Y. Iwashita,et al.  Expression of Matrix Metalloproteinase-7 is an Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma , 2012, Journal of Gastrointestinal Surgery.

[66]  Lei-bo Xu,et al.  Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma. , 2011, Hepatobiliary & pancreatic diseases international : HBPD INT.

[67]  Zhao-You Tang,et al.  Prediction of the Lymph Node Status in Patients with Intrahepatic Cholangiocarcinoma: Analysis of 320 Surgical Cases , 2011, Front. Oncol..

[68]  L. Tang,et al.  Prognostic significance of Beclin 1 in intrahepatic cholangiocellular carcinoma , 2011, Autophagy.

[69]  M. Kendrick,et al.  Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database. , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[70]  M. Nagino,et al.  Staging of Peripheral-Type Intrahepatic Cholangiocarcinoma: Appraisal of the New TNM Classification and its Modifications , 2011, World Journal of Surgery.

[71]  T. Janvilisri,et al.  Prognostic value of ABCG2 in moderately and poorly differentiated intrahepatic cholangiocarcinoma , 2011, Histopathology.

[72]  Masakazu Yamamoto,et al.  Mass‐forming intrahepatic cholangiocarcinoma with marked enhancement on arterial‐phase computed tomography reflects favorable surgical outcomes , 2011, Journal of surgical oncology.

[73]  H. Yu,et al.  Clinicopathologic Study on Combined Hepatocellular Carcinoma and Cholangiocarcinoma: with Emphasis on the Intermediate Cell Morphology , 2011, Journal of Korean medical science.

[74]  S. Ahn,et al.  Clinicopathological Characteristics in Combined Hepatocellular-Cholangiocarcinoma: A Single Center Study in Korea , 2011, Yonsei medical journal.

[75]  K. Hatakeyama,et al.  Ribonucleotide reductase M1 expression in intrahepatic cholangiocarcinoma. , 2011, Hepato-gastroenterology.

[76]  M. Fukayama,et al.  Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma , 2011, Virchows Archiv.

[77]  T. Takada,et al.  Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery , 2011, Journal of hepato-biliary-pancreatic sciences.

[78]  K. Hatakeyama,et al.  Original Article Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma , 2011 .

[79]  Y. Maehara,et al.  Different roles of S100P Overexpression in Intrahepatic Cholangiocarcinoma: Carcinogenesis of Perihilar Type and Aggressive Behavior of Peripheral Type , 2011, The American journal of surgical pathology.

[80]  A. Haug,et al.  18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[81]  Gang Liu,et al.  Prognostic Value of Cirrhosis for Intrahepatic Cholangiocarcinoma After Surgical Treatment , 2011, Journal of Gastrointestinal Surgery.

[82]  Sun-xiao Chen,et al.  Expression and prognostic significance of cancer-testis antigens (CTA) in intrahepatic cholagiocarcinoma , 2011, Journal of experimental & clinical cancer research : CR.

[83]  T. Pawlik,et al.  Intrahepatic cholangiocarcinoma: An international, multi-institutional analysis of prognostic factors and lymph node assessment. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84]  N. Yamada,et al.  Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma , 2012, Medical Molecular Morphology.

[85]  Jing Xu,et al.  Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. , 2010, World journal of hepatology.

[86]  S. Osada,et al.  Immunohistochemical study of claudin 18 involvement in intestinal differentiation during the progression of intraductal papillary mucinous neoplasm. , 2010, Anticancer research.

[87]  M. Matsuda,et al.  Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin , 2007, Hepatology.

[88]  Y. Mitani,et al.  Down‐regulation of the claudin‐18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype , 2006, The Journal of pathology.